Cargando…
Fatal Pyopneumothorax in a COVID-19 Patient
The COVID-19 pandemic has impacted every aspect of our lives since its start in December 2019. Among various COVID-19 complications, pleural complications are also increasingly reported but rarely from Nepal. Here, we presented a case of pyopneumothorax in a 52-year-old male patient referred from an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789894/ https://www.ncbi.nlm.nih.gov/pubmed/36579191 http://dx.doi.org/10.7759/cureus.31866 |
_version_ | 1784859056911941632 |
---|---|
author | Gurung, Anju Poudel, Dipesh Gurung, Bivek Rawal, Prabhat chapagain, Sunder |
author_facet | Gurung, Anju Poudel, Dipesh Gurung, Bivek Rawal, Prabhat chapagain, Sunder |
author_sort | Gurung, Anju |
collection | PubMed |
description | The COVID-19 pandemic has impacted every aspect of our lives since its start in December 2019. Among various COVID-19 complications, pleural complications are also increasingly reported but rarely from Nepal. Here, we presented a case of pyopneumothorax in a 52-year-old male patient referred from another center and admitted to the ICU of Nepal Armed Police Force Hospital with a diagnosis of severe COVID-19 pneumonia in the background of alcohol withdrawal syndrome with delirium tremens and generalized tonic-clonic seizures. He developed a rapid decline in respiratory status with a right-sided pneumothorax and underwent an immediate needle thoracostomy, followed by chest tube insertion. On the sixth day of admission, he had thick yellowish pus in the chest drain (pyopneumothorax), and despite the rigorous efforts in treatment, he died on the 15th day of admission. Though relatively uncommon, clinicians should consider pleural complications like pneumothorax, pleural effusion, pneumomediastinum, and empyema in patients with impaired immune status. In such patients, we should ensure prompt diagnosis with the earliest intervention and rationale use of antibiotics. |
format | Online Article Text |
id | pubmed-9789894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-97898942022-12-27 Fatal Pyopneumothorax in a COVID-19 Patient Gurung, Anju Poudel, Dipesh Gurung, Bivek Rawal, Prabhat chapagain, Sunder Cureus Infectious Disease The COVID-19 pandemic has impacted every aspect of our lives since its start in December 2019. Among various COVID-19 complications, pleural complications are also increasingly reported but rarely from Nepal. Here, we presented a case of pyopneumothorax in a 52-year-old male patient referred from another center and admitted to the ICU of Nepal Armed Police Force Hospital with a diagnosis of severe COVID-19 pneumonia in the background of alcohol withdrawal syndrome with delirium tremens and generalized tonic-clonic seizures. He developed a rapid decline in respiratory status with a right-sided pneumothorax and underwent an immediate needle thoracostomy, followed by chest tube insertion. On the sixth day of admission, he had thick yellowish pus in the chest drain (pyopneumothorax), and despite the rigorous efforts in treatment, he died on the 15th day of admission. Though relatively uncommon, clinicians should consider pleural complications like pneumothorax, pleural effusion, pneumomediastinum, and empyema in patients with impaired immune status. In such patients, we should ensure prompt diagnosis with the earliest intervention and rationale use of antibiotics. Cureus 2022-11-24 /pmc/articles/PMC9789894/ /pubmed/36579191 http://dx.doi.org/10.7759/cureus.31866 Text en Copyright © 2022, Gurung et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Infectious Disease Gurung, Anju Poudel, Dipesh Gurung, Bivek Rawal, Prabhat chapagain, Sunder Fatal Pyopneumothorax in a COVID-19 Patient |
title | Fatal Pyopneumothorax in a COVID-19 Patient |
title_full | Fatal Pyopneumothorax in a COVID-19 Patient |
title_fullStr | Fatal Pyopneumothorax in a COVID-19 Patient |
title_full_unstemmed | Fatal Pyopneumothorax in a COVID-19 Patient |
title_short | Fatal Pyopneumothorax in a COVID-19 Patient |
title_sort | fatal pyopneumothorax in a covid-19 patient |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789894/ https://www.ncbi.nlm.nih.gov/pubmed/36579191 http://dx.doi.org/10.7759/cureus.31866 |
work_keys_str_mv | AT gurunganju fatalpyopneumothoraxinacovid19patient AT poudeldipesh fatalpyopneumothoraxinacovid19patient AT gurungbivek fatalpyopneumothoraxinacovid19patient AT rawalprabhat fatalpyopneumothoraxinacovid19patient AT chapagainsunder fatalpyopneumothoraxinacovid19patient |